In both NCI‐N87 and SKOV3 cell lines, ebselen oxide also strongly blocked HER2 activation, an effect accompanied by reduced proliferation, revealing the potent action of ebselen oxide on several HER2+ cancers (Fig. 3). Here, ERBB2 is linked to cancer.